<DOC>
	<DOCNO>NCT01436032</DOCNO>
	<brief_summary>The purpose study determine analgesic efficacy safety N1539 subject undergoing abdominal laparoscopic surgery .</brief_summary>
	<brief_title>Efficacy , Safety Tolerability Study N1539 Subjects After Abdominal Laparoscopic Surgery</brief_title>
	<detailed_description />
	<mesh_term>Ketorolac</mesh_term>
	<mesh_term>Ketorolac Tromethamine</mesh_term>
	<criteria>Planning undergo elective abdominal laparoscopic surgery involve single site/organ intraperitoneal metastasis suspect identify Use ketorolac contraindicate Use general anesthesia contraindicate Has medical condition could adversely impact subject participation Has diabetes mellitus glycosylated hemoglobin ( HbA1c ) &gt; 9.5 history prolong uncontrolled diabetes Body mass index ( BMI ) less 18 great 35 Has history intolerance allergic reaction nonsteroidal antiinflammatory drug ( NSAIDs ) , Cox2 inhibitor , aspirin salicylate Known suspected sleep apnea History Hepatitis B C Has psychiatric disorder impairs capability subject report pain Known chronic obstructive pulmonary disease ( COPD ) carbon dioxide retention chronic hypoxemia</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>March 2012</verification_date>
</DOC>